10:51 AM EDT, 08/11/2025 (MT Newswires) -- Michael J. Farrell, Chief Executive Officer, on August 07, 2025, sold 8,009 shares in ResMed ( RMD ) for $2,238,379. Following the Form 4 filing with the SEC, Farrell has control over a total of 457,593 common shares of the company, with 455,503 shares held directly and 2,090 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/943819/000094381925000038/xslF345X05/form4.xml

Price: 285.07, Change: +1.17, Percent Change: +0.41